Clinical Trials Directory

Trials / Unknown

UnknownNCT02452541

TBI-Prognosis Multicenter Prospective Study

Early Determination of Neurological Prognosis in ICU Patients With Severe Traumatic Brain Injury: The TBI-Prognosis Multicenter Prospective Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
315 (actual)
Sponsor
CHU de Quebec-Universite Laval · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Severe traumatic brain injury (TBI) is the leading cause of death and disability among people under 45 years of age and a major public health problem. Although management of severe TBI patients has gradually improved with the establishment of intensive care units (ICU) and the development of practice guidelines, mortality is still high - ranging from 30 to 50% - with 30% of survivors suffering from severe neurological sequelae such as neurovegetative states. Families and medical teams are frequently called upon to determine reasonable and appropriate goals of care for brain injured patients. They may have to consider high intensity of care, but also the withdrawal of life-sustaining therapies in accordance with patient wishes. Physicians involved in the care of severe traumatic brain injury have expressed serious concerns about hasty decisions made in the absence of appropriate evidence of unfavourable prognosis. The purpose of the TBI-Prognosis study is to develop a prognostic model by using a multimodal approach of different prognostic indicators and their evolution over time in the acute phase of care. The results of this study will provide better objective information that will facilitate the shared-decision making-process with families and relatives.

Conditions

Interventions

TypeNameDescription
OTHERPrognostic tests* Brain CT-Scan on day 1, 3 and 7 * Brain MRI on day 7 * SomatoSensory Evoked Potentials on day 7 * Electroencephalogram on day 7 * Serum biomarkers on day 1, 3 and 7 * Daily clinical exams

Timeline

Start date
2013-04-01
Primary completion
2017-02-01
Completion
2017-09-01
First posted
2015-05-22
Last updated
2016-06-09

Locations

17 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT02452541. Inclusion in this directory is not an endorsement.